20 BIOTECH IN BAVARIA REPORT 2016/17 including more than 300 company managed by profiles and contact addresses 291 m 99 m 10 nm 2962 m Gipfelstürmern bieten wir in Penzberg die beste Basis. Roche in Penzberg ist aktiver Teil der Life-Science-Region Greater Munich. Als Powerhouse für Antikörper haben wir hohe Ziele. Mit Mut zu neuen Ideen, dem Willen zur Lösung drängender Gesundheitsfragen und gelebter kultureller Vielfalt arbeiten wir global vernetzt an den Gesundheitslösungen von morgen. From Science to Patients. accelerating biomedical innovation BioM – central point of contact for pharma and biotechnology in Munich and Bavaria ❚ consulting for founders-to-be, ❚ representing Bavarian biotechnology start-ups & SMEs world-wide ❚ grant & seed fi nancing support ❚ investment opportunities ❚ pre-seed incubation & m4 award ❚ central online platform: ❚ matchmaking, networking & partnering job exchange, company database ❚ events, conferences & training and much more www.bio-m.org accelerating biomedical innovation M Bio – central point of contact for Imprint Editorial staff: Dr. Almut Windhager, pharma and biotechnology in Munich Dr. Georg Kääb Company Profiles: Dr. Christina Grimm Dr. Andreas Berghammer and Bavaria Data analysis was compiled together with BIO-Deutschland e.V., special thanks to Nicole Kukuk and Florian Matznick. ❚ consulting for founders-to-be, ❚ representing Bavarian biotechnology We thank the Bavarian companies and the regional organizations of the Bavarian Biotechnology Cluster for start-ups & SMEs world-wide supporting this survey. ❚ grant & seed fi nancing support ❚ investment opportunities April, 2017 ❚ pre-seed incubation & m4 award ❚ central online platform: ❚ matchmaking, networking & partnering job exchange, company database ❚ events, conferences & training and much more Contact Prof. Dr. Horst Domdey, Managing Director Spokesman of the Bavarian Biotechnology Cluster The Bavarian and the Munich Biotechnology Clusters are managed by: BioM Biotech Cluster Development GmbH Am Klopferspitz 19 a D-82152 Martinsried Phone: +49 (0)89-89 96 79-0 Fax: +49 (0)89-89 96 79-79 E-Mail: [email protected] Internet: www.biotech-bavaria.de # www.bio-m.org The layout, graphics and other contents of this brochure of the Bavarian Biotechnology Cluster are protected by copyright law. Layout-Design: MxM, Munich, www.mxm.de Pictures copyright as indicated Supported by the Bavarian Ministry of Economic Affairs and Media, Energy and Technology www.stmwi.bayern.de/en/ www.bio-m.org 3 Ihr Hightech-Unternehmen NEU: Wachstumsfonds sucht Eigenkapital? Bayern Bayern Kapital bietet: • Eigenkapital für Seedphase, F&E, Markteinführung und Wachstum • Co-Investments mit Partnern WWW.BAYERNKAPITAL.DE • Langjährige Finanzierungserfahrung Bayern Kapital GmbH | Ländgasse 135 a | 84028 Landshut Telefon 0871 92325-0 | [email protected] • Zugang zu einem starken Netzwerk BREEDINGBREEDING GROUND GROUND FOR FOR INNOVATIONS INNOVATIONS OurOur Network Network of of Universities Universities and and UniversitiesUniversities of of Applied Applied Sciences Sciences CoburgCoburg HofHof BambergBamberg BayreuthBayreuth AschaffenburgAschaffenburg NürnbergNürnberg / Erlangen / Erlangen WürzburgWürzburg / Schweinfurt / Schweinfurt Amberg-WeidenAmberg-Weiden AnsbachAnsbach RegensburgRegensburg DeggendorfDeggendorf IngolstadtIngolstadt PassauPassau Neu-UlmNeu-Ulm Weihenstephan-TriesdorfWeihenstephan-Triesdorf LandshutLandshut AugsburgAugsburg RosenheimRosenheim KemptenKempten MünchenMünchen #happy20#happy20thanniversaryBiothanniversaryBioM M BAYERISCHEBAYERISCHE PATENTALLIANZ PATENTALLIANZ www.baypat.dewww.baypat.de Ihr Hightech-Unternehmen NEU: Content Wachstumsfonds sucht Eigenkapital? Biotech in Bavaria - looking back and across 7 Bayern Prof. Dr. Horst Domdey – Spokesman Bavarian Biotechnology Cluster Bayern Kapital bietet: Biopharma in Bavaria at a glance 9 • Eigenkapital für Seedphase, F&E, Markteinführung und Wachstum Facts and Figures 2016 10–13 Companies 10-11 • Co-Investments mit Partnern Employment 12–13 WWW.BAYERNKAPITAL.DE • Langjährige Finanzierungserfahrung Bayern Kapital GmbH | Ländgasse 135 a | 84028 Landshut Bavarian Biotech Cluster - Trends and Topics 14–21 Telefon 0871 92325-0 | [email protected] Zugang zu einem starken Netzwerk Trends and Topics 14-15 • Spotlight on Munich 16-17 Founding and Incubation 18 Biotech Centers in Bavaria 20-21 BREEDING GROUND FOR INNOVATIONS Timeline: 20 Years Munich Biotech Cluster - 20 Years BioM 22-27 Our Network of Universities and Universities of Applied Sciences Company Profiles 29–160 in alphabetical order Coburg Hof Bamberg Bayreuth Aschaffenburg Nürnberg / Erlangen Amberg-Weiden Würzburg / Schweinfurt About this survey: Ansbach Regensburg For the following report, a biotechnology company has been defined as a company, which develops and/ or manufactures products on the basis of state-of-the-art molecular biological methods. Since “conventi- Deggendorf onal” pharmaceutical companies are increasingly also using such methods, it is often difficult to differen- Ingolstadt tiate between biotech and pharma. We conducted separate surveys for biotech companies, pharmaceutical Passau companies, (pre)clinical contract research organizations (CROs), contract manufacturing organizations Neu-Ulm (CMOs), suppliers and others with activities in the biotechnology sector. When referring to biotech Weihenstephan-Triesdorf companies, a distinction was once again made between small and medium-sized companies (SMEs/nati- Landshut ve Biotech) having their headquarters in Bavaria on the one hand, and branch offices and subsidiaries of Augsburg national and international biotech companies (international biotech or non-SMEs) on the other hand. The term “non-SME” therefore gives no indication about the actual size of this branch office. The data were collected in cooperation with BIO-Deutschland e.V.. It was possible to achieve a response rate of almost 70 %. Possible deviations from previously published figures are the result of additional data obtained in this survey that also may refer to previous years. The period under review for this report is the year 2016. Rosenheim Company profiles: There are about 300 companies listed in the appendix of this brochure (pp. 21). Not every company being listed is also “counted” in this survey (for example some companies with very specific services or Kempten München those few from the medtech area), and there are further Bavarian biotech and pharma companies having not activated their listing. Published in April 2017 #happy20thanniversaryBioM BAYERISCHE PATENTALLIANZ www.baypat.de 5 Bei Amgen sind biologische Arzneimittel in Qualität verwurzelt und werden von Zuverlässigkeit genährt. Eine solide Qualitätskontrolle und zuverlässige Versorgung sind genau so wichtig wie wissenschaftliche Innovationen. Seit mehr als drei Jahrzehnten wird bei Amgen jedes Medikament mit Engagement, Leidenschaft und dem Streben nach Perfektion hergestellt. Darum finden Sie bei Amgen die Biologika, die für die Behandlung Ihrer Patienten so enorm wichtig sind. Und das auch für die zukünftigen Generationen. Weitere Informationen über Amgens Engagement für eine gleichbleibende Qualität und zuverlässige Versorgung finden Sie unter biotechnologybyamgen.de. ©2013 Amgen Inc. Alle Rechte vorbehalten. AMG-DEU-AMG-021-2014-January-P (1/2014) RZ_AMG-DEU-AMG-021-2014-April-P+DE_non+product+specific_Anzeige+Biotechnology+by+Amgen_210x297.indd 1 08.04.14 18:31 Biotech in Bavaria - looking back and across Looking back over my shoulder . is not only one of companies with a my favorite songs (by Mike & The Mechanics), but positive cash flow also one of my main activities since we started to based on their prepare this year’s Bavarian biotech report. As most marketed products, of you know, the Munich Biotech Cluster originally technologies and (and at least formally) began with the creation and services – not only foundation of BioM 20 years ago in the spring of locally or on the 1997. In the years before, the foundation of several national level, but biotech companies had formed a sound basis for worldwide. Second, Munich’s application in the national BioRegio Com- innovative busi- petition, in which Munich became one of the three ness concepts have winners in 1996, receiving an award of 50 million been identified and Deutsche Mark to be distributed to the emerging financially suppor- Munich biotech companies. ted in a straightfor- ward way for many PROF. DR. Looking back, the Munich biotech industry had an years. This has HORST DOMDEY almost perfect start in those times of the roaring created new start- BioM; Spokesman Bavarian Biotechnology Cluster high-tech 1990s, when (almost) every tech-dream up companies on looked easy to achieve. It was the flourishing years a strong and very of the still young and not yet negatively perceived professional basis. “Neuer Markt”. The cluster grew on the fertile basis To some extent, this is due to the efforts of BioM provided by the excellent research carried out at about 15 years ago, when we developed innovati- many scientific institutions in Munich. The number of ve funding concepts which finally became the basis companies increased by 50 % per year, the number for the now available EXIST, GO-Bio and m4 Award of employees even doubled from year to year, and programs. Furthermore, BioM offers a comprehensive in 2000, the incredible amount of 500 million Euro incubation program for biotech entrepreneurs-to-be. was invested in the local biotech industry. Last but not least, due to Munich’s